105 related articles for article (PubMed ID: 16802602)
1. The adapter 3BP2: how it plugs into leukocyte signaling.
Deckert M; Rottapel R
Adv Exp Med Biol; 2006; 584():107-14. PubMed ID: 16802602
[No Abstract] [Full Text] [Related]
2. Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.
Levaot N; Voytyuk O; Dimitriou I; Sircoulomb F; Chandrakumar A; Deckert M; Krzyzanowski PM; Scotter A; Gu S; Janmohamed S; Cong F; Simoncic PD; Ueki Y; La Rose J; Rottapel R
Cell; 2011 Dec; 147(6):1324-39. PubMed ID: 22153076
[TBL] [Abstract][Full Text] [Related]
3. PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism.
Matsumoto Y; Rottapel R
Trends Mol Med; 2023 May; 29(5):390-405. PubMed ID: 36948987
[TBL] [Abstract][Full Text] [Related]
4. [The adaptor protein 3BP2 in leukocyte signaling].
Deckert M
Med Sci (Paris); 2006 Dec; 22(12):1081-6. PubMed ID: 17156730
[TBL] [Abstract][Full Text] [Related]
5. Adaptor protein 3BP2 and cherubism.
Hatani T; Sada K
Curr Med Chem; 2008; 15(6):549-54. PubMed ID: 18336269
[TBL] [Abstract][Full Text] [Related]
6. Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function.
Miah SM; Hatani T; Qu X; Yamamura H; Sada K
Genes Cells; 2004 Nov; 9(11):993-1004. PubMed ID: 15507112
[TBL] [Abstract][Full Text] [Related]
7. [Molecular and Cellular Pathogenesis of Cherubism].
Ueki Y
Clin Calcium; 2016 Jun; 26(6):918-26. PubMed ID: 27230848
[TBL] [Abstract][Full Text] [Related]
8. Bone dynamics and inflammation: lessons from rare diseases.
Matsumoto Y; Rottapel R
Immunol Med; 2020 Jun; 43(2):61-64. PubMed ID: 31999934
[TBL] [Abstract][Full Text] [Related]
9. [Gene mutation and expression of SH-3BP-2 in cherubism].
Li YW; Meng XM; Yu SF; Gao P
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Apr; 44(4):227-31. PubMed ID: 19576004
[TBL] [Abstract][Full Text] [Related]
10. Novel treatment of a rare genetic bone disease.
McMahon MS
Orthopedics; 2007 Feb; 30(2):91. PubMed ID: 17323628
[No Abstract] [Full Text] [Related]
11. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
[TBL] [Abstract][Full Text] [Related]
12. Jawing about TNF: new hope for cherubism.
Novack DV; Faccio R
Cell; 2007 Jan; 128(1):15-7. PubMed ID: 17218248
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.
Lietman SA; Kalinchinko N; Deng X; Kohanski R; Levine MA
Hum Mutat; 2006 Jul; 27(7):717-8. PubMed ID: 16786512
[TBL] [Abstract][Full Text] [Related]
14. Cherubism Study Results May Apply to Common Inflammatory Bone Diseases.
Dent Today; 2015 May; 34(5):54. PubMed ID: 26473261
[No Abstract] [Full Text] [Related]
15. The 3BP2 adapter protein is required for chemoattractant-mediated neutrophil activation.
Chen G; Dimitriou I; Milne L; Lang KS; Lang PA; Fine N; Ohashi PS; Kubes P; Rottapel R
J Immunol; 2012 Sep; 189(5):2138-50. PubMed ID: 22815290
[TBL] [Abstract][Full Text] [Related]
16. The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response.
Chen G; Dimitriou ID; La Rose J; Ilangumaran S; Yeh WC; Doody G; Turner M; Gommerman J; Rottapel R
Mol Cell Biol; 2007 Apr; 27(8):3109-22. PubMed ID: 17283041
[TBL] [Abstract][Full Text] [Related]
17. SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism.
Lietman SA; Prescott NL; Hicks DG; Westra WH; Levine MA
Clin Orthop Relat Res; 2007 Jun; 459():22-7. PubMed ID: 17545756
[TBL] [Abstract][Full Text] [Related]
18. The role of SH3BP2 in the pathophysiology of cherubism.
Reichenberger EJ; Levine MA; Olsen BR; Papadaki ME; Lietman SA
Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S5. PubMed ID: 22640988
[TBL] [Abstract][Full Text] [Related]
19. SHP-1 dephosphorylates 3BP2 and potentially downregulates 3BP2-mediated T cell antigen receptor signaling.
Yu Z; Maoui M; Zhao ZJ; Li Y; Shen SH
FEBS J; 2006 May; 273(10):2195-205. PubMed ID: 16649996
[TBL] [Abstract][Full Text] [Related]
20. A new mutation in the SH3BP2 gene showing reduced penetrance in a family affected with cherubism.
de Lange J; van Maarle MC; van den Akker HP; Redeker EJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):378-81. PubMed ID: 17321449
[No Abstract] [Full Text] [Related]
[Next] [New Search]